Logo image
Distinctive patterns of Her‐2/neu, c‐myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers
Journal article   Open access

Distinctive patterns of Her‐2/neu, c‐myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers

Laura E. Janocko, Kathryn A. Brown, Charles A. Smith, Ling Ping Gu, Agnese A. Pollice, Sarita G. Singh, Thomas Julian, Norman Wolmark, Lillian Sweeney, Jan F. Silverman, …
Cytometry (New York, N.Y.), v 46(3), pp 136-149
15 Jun 2001
PMID: 11449404
url
https://doi.org/10.1002/cyto.1098View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

aneuploidy breast cancer cyclin D1 c‐myc Her‐2/neu p53
Background: Human solid tumors undergo clonal evolution as they progress, but evidence for specific sequences of genetic changes that occur in individual tumors and are recapitulated in other tumors is difficult to obtain. Methods: Patterns of amplification of Her‐2/neu, c‐myc, and cyclin D1 were determined by fluorescence in situ hybridization (FISH) in relation to the presence of p53 dysfunction and ploidy in 60 primary human breast cancers. Results: We show that there are clusters of genophenotypic abnormalities that distinguish lobular breast cancers from nonlobular tumors; that cyclin D1 amplification occurs prior to the divergence of lobular breast cancers from nonlobular cancers; that p53 dysfunction, Her‐2/neu amplification, and c‐myc amplification are characteristic features of nonlobular breast cancers, but not of lobular breast cancers; and that the frequencies of amplification of all three oncogenes examined increase progressively with increasing aneuploidy, but that each gene exhibits a different profile of increasing amplification in relation to tumor progression. Early amplification of c‐myc appears to be an especially prominent feature of hypertetraploid/hypertetrasomic tumors. Conclusions: The data suggest that in tumors containing multiple abnormalities, these abnormalities often accumulate in the same cells within each tumor. Furthermore, the same patterns of accumulation of multiple genophenotypic abnormalities are recapitulated in different tumors. Cytometry (Comm. Clin. Cytometry) 46:136–149, 2001. © 2001 Wiley‐Liss, Inc.

Metrics

5 Record Views
41 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemical Research Methods
Cell Biology
Logo image